Table 1. Biochemical characteristics of patient 1.
| Characteristics | Reference | Days after admission |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | 8a | 13b | 15c | 16c | 17c | 18 | 24 | 25c | 26 | ||
| TB (µmol/L) | 5–21 | 411.8 | 513.6 | 532.3 | 616.4 | 570.3 | 353.8 | 453.3 | 417.8 | 524 | 561.5 | 378.5 |
| IB (µmol/L) | <7 | 266.3 | 370.6 | 379.1 | 450.1 | 427.7 | 274.9 | 374.3 | 352.7 | 428.6 | 490.4 | 330.4 |
| DB (µmol/L) | – | 145.5 | 143 | 153.2 | 166.3 | 142.6 | 78.9 | 79 | 65.1 | 95.4 | 71.1 | 48.1 |
| ALB (g/L) | 40–55 | 23.8 | 27.8 | 27.4 | 39.4 | 35.9 | 35.7 | 46.2 | 43.3 | 41.3 | 42.2 | 43.2 |
| BAMR | – | 1.1 | 1.2 | 1.3 | 1.0 | 1.0 | 0.7 | 0.6 | 0.6 | 0.8 | 0.9 | 0.6 |
| ALT (U/L) | 9–50 | 54 | 60 | 62 | 64 | 130 | 81 | 79 | 75 | 108 | 93 | 75 |
| AST (U/L) | 15–40 | 148 | 152 | 147 | 164 | 366 | 207 | 206 | 184 | 207 | 191 | 150 |
| GGT (U/L) | 10–60 | 114 | 99 | |||||||||
| ALP (U/L) | 45–125 | 474 | 412 | |||||||||
| TBA (µmol/L) | <10 | 175.3 | 122.8 | |||||||||
| WBC (×109/L) | 3.5–9.5 | 6.68 | 5.54 | 8.26 | 7.47 | 7.02 | 7.2 | 6.87 | 4.21 | 6.25 | 4.08 | 7.69 |
| N% | 40–75 | 81.5 | 71.1 | 80.1 | 83.2 | 75.8 | 72.8 | 72.7 | 83.4 | 75.9 | 71.6 | 90.1 |
| HGB (g/L) | 130–175 | 109 | 112 | 105 | 80 | 82 | 78 | 85 | 80 | 65 | 62 | 68 |
| PLT (×109/L) | 125–350 | 145 | 138 | 128 | 85 | 87 | 81 | 90 | 89 | 85 | 70 | 75 |
| Amon (µg/dL) | 19–54 | 16 | 25 | 123 | 79 | 20 | 8 | 25 | 48 | 59 | ||
a
The patient’s neuropsychiatric symptoms deteriorated after hematemesis.
b
The patient underwent plasma exchange.
c
The patient underwent DPMAS and plasma exchange.
Abbreviations: %N, proportion of neutrophils; ALB, albumin; ALP, alkaline phosphatase; Amon, blood ammonia; BAMR, Bilirubin-albumin molar ratio; DB, direct bilirubin; GGT, γ-glutamyl transferase; HGB, hemoglobin; IB, indirect bilirubin; PLT, platelets; TBA, total serum bile acid; WBC, white blood cell.